- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Live Event – All Hands On Deck In The Treatment Of Major Depressive Disorder (MDD): A Focus On Measurement-Based Care In Psychiatry & Primary Care
About This Event
Live Event – All Hands On Deck In The Treatment Of Major Depressive Disorder (MDD): A Focus On Measurement-Based Care In Psychiatry & Primary Care
This is a Live Event for PsychU members in New York and New Jersey.
Given the current state of affairs, primary care providers are increasingly treating patients with Major Depressive Disorder (MDD). During this panel presentation, Savatta Salvatore, MD; Michael Townsend, MA, LCSW; and C. Brendan Montano, MD, will be discussing the prevalence and burden of MDD within the Tri-State area (NY/NJ/CT), with an emphasis on New Jersey and the impact of COVID-19 on MDD. Additionally, the speakers will discuss barriers faced by primary care providers and include the perspectives and expertise from psychiatrists. Finally, the presenters will consider the potential role of measurement-based care, focusing on the strategies incorporated in their practices and discussing methods of collaboration.
Objectives:
- Discuss the prevalence and burden of Major Depressive Disorder (MDD) locally and nationally, including the impact of COVID-19
- Identify gaps between primary care and psychiatry within the treatment of MDD
- Understand the potential role and importance of measurement-based care (MBC)
- Consider methods of collaboration that may improve outcomes for patients with MDD
Venue
Spanish Tavern
103 McWhorter St A
Newark, New Jersey 07105 United States + Google Map(973) 589-4959 View Venue WebsiteFeaturing
Salvatore G. Savatta, MD
Chair of Psychiatry, Trinitas Regional Medical Center, Elizabeth, NJ
MoreDr. Salvatore G. Savatta received his Bachelor of Arts degree in Economics from New York University, graduated from New York University School of Medicine in 2001 and completed his M.S. in Biostatistics Clinical Research Methods at Columbia University’s Mailman School of Public Health in 2005. Dr. Savatta has previously served as Director of Inpatient Psychiatry at New York Methodist Hospital, Medical Director of TMS Centers of America and both Deputy Chair and Interim Chair of Psychiatry at Trinitas Regional Medical Center. He presently serves as Chair of Psychiatry at Trinitas and has done so since May of 2020. Dr. Savatta completed his Psychiatry Residency at St. Vincent’s Catholic Medical Center and completed a Public Service Psychiatry Fellowship and a Forensic Psychiatry Fellowship at the University of Pittsburgh Medical Center – Western Psychiatric Institute and Clinic. Dr. Savatta is Board Certified in both Adult Psychiatry and Forensic Psychiatry. He has tailored his clinical practice to focus on “difficult to treat” depression, and often includes the implementation of Neuromodulation techniques such as TMS, Esketamine, and Electroconvulsive Therapy (ECT) when clinically appropriate.Michael Townsend, MA, LCSW
Deputy Chief Executive Officer, Gateway Counseling Center
C. Brendan Montano, MD, PC
Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut
MoreDr. Montano is Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut, where he also holds a private practice in internal medicine, specializing in preventative medicine and mood disorders. In addition, he is an attending physician at Middlesex Memorial Hospital in Middletown, Connecticut.Brijesh Patel, PharmD (OPDC)
Clinical & Scientific Liaison
Becky Wong, PharmD, MBA (OPDC)
Clinical & Scientific Liaison
Speakers Salvatore G. Savatta, MD; Michael Townsend, MA, LCSW; and C. Brendan Montano, MD, PC are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Brijesh Patel, PharmD and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
-
Live Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State
February 15 6:00 pm to 8:30 pm -
Live Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State
February 22 6:00 pm to 8:30 pm -
Live Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia
February 28 6:30 pm to 9:00 pm
Registration
PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.
Stay Connected: